Back to SO Soros Fund Management LLC
KYMR
2 quarters
Position history for SOSoros Fund Management LLC's holdings in Kymera Therapeutics, Inc.
No. Soros Fund Management exited its KYMR (Kymera Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 120,373 shares worth $4.8M. Soros Fund Management first reported KYMR in Q4 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$4.8M
Total Shares Change
-120,373
Quarter-by-Quarter History